chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Getting a pain in my left eye and between my leg  and  my stomach; getting sharp pain every 3 minutes since  I had my shot; Getting a pain in my left eye and between my leg  and  my stomach; getting sharp pain every 3 minutes since  I had my shot; Getting a pain in my left eye and between my leg  and  my stomach; getting sharp pain every 3 minutes since  I had my shot; Abdominal pain; Chills; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN UPPER (non-serious), EYE PAIN (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "Getting a pain in my left eye and between my leg  and  my stomach; getting sharp pain every 3 minutes since  I had my shot"; ABDOMINAL PAIN (non-serious), outcome "unknown", described as "Abdominal pain"; CHILLS (non-serious), outcome "unknown", described as "Chills"; DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea".  Additional information: consumer stated that, "I am getting a pain in my left eye and between my leg and my stomach, I am getting sharp pain every 3 minutes since  I had my shot, yesterday I had my shot."  Further consumer stated, "I had the COVID shot yesterday the first one, by Pfizer. And I am having abdominal pain like every 3 minute. I am not sure if I have to go to the hospital. And I am having chills and diarrhea." Consumer was informed about the role of Pfizer Medical Information and offered the number. Consumer was provided with the number of Pfizer Medical Information and was requested to select option 3, timings as 8 am to 8 pm Monday to Fridays and 9 am to 3 pm on Saturday and Sunday as per (EST).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
rash; It is blistered slightly and it is a little itchy but it is not overwhelming; It is blistered slightly and it is a little itchy but it is not overwhelming; This is a spontaneous report from a contactable consumer (Patient). An 84-year-old female patient received second dose of BNT162B2 (Pfizer COVID-19 Vaccine, Solution for injection, Lot number was not reported, NDC number: 59267-1000-01), via an unspecified route of administration on 27Feb2021 as (dose reported as 0.3) single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient took first dose of BNT162B2 on 06Feb2021 and patient experienced slight rash. On an unspecified date, patient experienced rash and at the time of report she still had some of that a little bit more and it was blistered slightly, and it was a little itchy, but it was not overwhelming. Patient thought it should be passed and reported. Patient wanted to know if an Epsom salt bath was okay to take. Patient would like to take an Epsom salt bath. It was not medication. The doctor gave her some Cortisone. It was neither here nor there, it was not that severe. Patient had not done any lab work. The outcome of the events was reported as unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Patient woke up form nap early afternoon on 5/5/13 noted to be hot and then had a 1.5 min seizure. He vomited once after seizure. This patient has a history of seizure-none in last year until now. Patient was transported to hospital for evaluation.
Shingles; rash was painful and itchy was on the face, head, neck, and along their right side; rash was painful and itchy was on the face, head, neck, and along their right side; painful; This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st April 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced shingles, pain, generalized rash and itchy rash. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the shingles, pain, generalized rash and itchy rash were recovered/resolved.   It was unknown if the reporter considered the shingles, pain, generalized rash and itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received first dose of Shingrix and experienced a confirmed case of Shingles. The patient reported that the rash was painful and itchy and was on the face, head, neck, and along their right side. The pain and itch resolved after approximately 4 or 5 days, with use of antivirals prescribed by the health care professionals. The reporter reported rash resolved a few weeks ago from reporting date. Till the time of reporting, patient did not receive 2nd dose of Shingrix vaccine. No patient demographics was provided. All information provided had been reported. No additional details to provide.  The reporter did not consent to follow-up.
This is one case out of a cumulative total of 235 cases solicited from the EDSS database during the surveillance period from 01 January 2010 to 23 September 2014. These 235 cases represent children who received 3 or more doses of Sanofi Pasteur vaccine; cases of pertussis disease in children who received DTaP combination vaccines from other manufacturers are not reported as per study protocol. Initial report was received on 23 September 2014 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in a 14 month-old male subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received three doses of PENTACEL; dose one on 23 August 2013 (lot number C4478AB), dose two on 01 November 2013 (C4478AB) and dose three on 17 January 2014 (lot number C4577AA) (routes and sites of administration for all doses not reported). Approximately 225 days after the last dose, on 30 August 2014, the subject developed a cough. Five days later, on 04 September 2014, the subject developed a paroxysmal cough. The subject also experienced post-tussive vomiting and sleep disturbance on an unspecified date. Laboratory testing included a positive PCR on 08 September 2014. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 09 September 2014 for five days. The subject was not hospitalized. At the time of final contact on 15 September 2014, the subject's cough was still persisting. The duration of the cough was reported at that time as 16 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Mother states Left arm with redness and edema "the size of 2 fists".  Area tender to touch, though child moves arm without difficulty.  States she has used cold compresses without success.  Denies fever.  Recommended warm compresses and either Tylenol of Ibuprofen for symptomatic relief. To call physician on 4/1/08 if no improvement.
-felt extremely fatigued, not able to walk or move for 30 mins after the vaccination -felt a melting sensation -got blood pressure taken and it was normal  -extremely faint -tried to slow down breathing with bigger + longer breaths because of the uncomfortable feeling -major nausea after getting up and sitting down again (lasted 2 mins) -nurse said it may be because of low sugar levels, drank coconut water
Irritability, nasal congestion, and cough began 9am 10/23/2018; Fever 12/12:30 10/23/2018; Difficulty sleeping 1pm 10/23/2018.
Vomiting; Headache; This is a spontaneous report from a contactable consumer. A 63-years-old male consumer (patient) reported for himself that he received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 28Jan2021 at 09:30 in left arm as a single dose for covid-19 immunization. Medical history included hypothyroidism, restless leg, high blood pressure and stroke all from an unknown date and unknown if ongoing. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Treatment received for the adverse event was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin, clopidogrel and tamsulosin hydrochloride (FLOMAX [TAMSULOSIN HYDROCHLORIDE]); all start and stop date were not reported and used for unspecified indication. The patient experienced headache, vomiting on 28Jan2021 at 15:00. The events were reported as non serious. The outcome of both events was recovering/resolving.  Information on the lot/batch number has been requested.  Follow-up (15Apr2021): This follow-up is being submitted to notify that the batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
Erythema multiformans, ecchymosis, itching and swelling of feet.
Patient came in for Moderna bivalent booster. Was given 0.5mL of Moderna primary 6yr-11yr.
Pfizer vaccine -  12 hours later  - severe migraine along with other expected symptoms such as fever, chills, etc. 24 hours later - lethargy remained 36 hours later - extreme joint pain.  Took opioid pain killers and anti-inflammatory meds.  Contacted dr.  Still monitoring at 2 1/2 weeks out.  Pain has lessened but is still present.
Headache, Arthralgia, Fever, NauseaVomiting, weakness, "rolling bowels but no diarrhea" Narrative:  Fever 100.7, weakness, headache, arthralgia, nausea,  upset stomach, fatigue chills; took tylenol. Resolved within 48 hours.  Other Relevant History:
patient received Menveo subcutaneously.; This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 19-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 31st May 2021, the patient received Menveo (subcutaneous). On 31st May 2021, unknown after receiving Menveo, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional details were reported as follows: The patient received Menveo subcutaneously which led to intramuscular formulation administration by other route. The reporter consented to follow up.
In October 2022, I had a sudden sharp drop in my blood sugar level. I went to the emergency room. I had an elevated hormone and it was discovered that I had an elevated blood level igf2.
Tingling in chest "tight" in chest. Tingling hands. Hypertensive crisis with dizziness. Evaluated by EMS- Transported to Emergency room/department or urgent care.
I noticed a cold sore this afternoon  and wondered whether it might be related to the vaccine. I am not otherwise sick and am very careful to clean my hands and not touch my face.
Photophobia & red, gritty & painful eyes post inject; Both eyes red & watery; Sensation of sand in the eyes;
Next day felt a bit winded when talking; heart rate high and shortness of breath with minimal exercise about 24 hours after injection, and joint pain started.  Within a couple of hours, had chills, myalgias, severe abdominal pain, and spine pain.  Fever 99.4, then 100.4 for about 12 hours.  Went to sleep and woke up with mild headache.  Was completely better by 10AM the next day Note: I had COVID-19 10/28/20 (date of positive test); my antibody tests at 8 and 12 weeks have been negative
muscle spasms; itching; This spontaneous report as received from a medical assistant refers to a female patient of an unknown age. The patient had no pertinent medical history, concomitant medications, and drug reactions or allergies.  On 13-MAY-2020, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # R028656, expiration date 27-JUL-2020, intramuscularly (strength was not reported) for human papillomavirus (HPV) prevention.  On an unknown date, the patient experienced muscle spasms and itching. The patient did not receive any treatment for adverse events. No lab diagnostics or studies were performed. The patient sought medical attention and had an office visit on 22-JUL-2020. The outcome of muscle spasms and itching was reported as not recovered.  The causality assessment was not provided. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R028656; expirationdate: 27-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Pain in left arm 1 hour post injection, for 5 hours after the shot, followed by chills, fever, general sense of "being off". Next day, same symptoms, along with change in taste (not loss- everything tasted very off, slightly metallic), vomiting (1x), shaking, loss of appetite. Slight arm pain throughout morning, shakiness throughout day, felt like I was freezing all thru Friday night to Saturday morning, despite excessive sweating. General shakiness and loss of  appetite, altered sense of taste thru time of reporting.
Feel like I have the flu; Dry heaving; Fever of 101.3; Lots of joint pain; Headache; Fatigue; Nausea; Chills; A spontaneous report was received from a 53-year-old, female consumer who received Moderna's COVID-19 vaccine and developed headache, fatigue, joint pain, flu-like feeling, nausea, dry heaving, chills, and fever of 101.3.  The patient's medical history, as provided by the reporter, included COVID-19 infection. No relevant concomitant medications were reported.  On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) for prophylaxis of COVID-19 infection.     On 28 Dec 2020, the patient developed headache, fatigue, joint pain, flu-like feeling, nausea, dry heaving, chills, and fever of 101.3. Treatment for the events included Tylenol on 28 Dec 2020.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome for the events developed headache, fatigue, joint pain, flu-like feeling, nausea, dry heaving, chills, and fever of 101.3 were considered not recovered.; Reporter's Comments: This case concerns a 53-year-old, female consumer with medical history of COVID-19 infection, who experienced NS, expected event of headache, fatigue, chills, pyrexia, arthralgia, nausea and unexpected events of influenza-like symptoms and retching. The events occurred the day the first dose of mRNA-1273 (Lot number: 011J20A) was administered. Treatment for the events included Tylenol.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Had the vaccine....got it anyway... sound familiar /Suspected Vaccination Failure; Had the vaccine....got it anyway... sound familiar; They are extremely painful..; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, got shingles after vaccination with shingles vaccine. The shingles were extremely painful. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
soreness on collarbone, left hand side, lymph nodes above and below collar bone obviously swollen.  Started Saturday morning, more swollen and sore on Sunday.
Extreme body aches. Fever (101.9) - 3 days. Upper respiratory issues (prolonged coughing all night/day). Shortness of breath (cannot exercise). Pressure on chest above heart. Feelings of heart palpitations. Exhaustion. Cannot sleep well.
Moderate pain in the back of right leg/calf area beginning the night of Aug 25 2021, around 8 pm. Increasinly more painful with a feeling of tightness, especially upon walking. I elevated and iced area and after 2 hrs called nurse hotline on back of insurance card. Took a Tylenol and Flexeril. No improvement by Thurs morning. Went to an Urgent Care clinic by 2 pm Thurs. FNP said blood flow was good but noticed swelling and discoloration. Pain upon touch but no warmness, fever, or severe pain upon flexing, only moderate. Was prescribed 10 mg of prednisone for 4 days. Was told likely inflammation. Improvement after 3 days of the steroids.
Today he asked me if photosensitivity is an issue. He has been experiencing a noticeable increase for the past 2 days.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Batch/Lot number: unknown) as dose 1 single for covid-19 immunisation. Relevant medical history included: "type 2 diabetic" (unspecified if ongoing); "obese" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PHOTOSENSITIVITY REACTION (non-serious), outcome "unknown", described as "Today he asked me if photosensitivity is an issue. He has been experiencing a noticeable increase for the past 2 days.".  Additional information: He was not suspected to have ever had Covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 7MAY97 & seen 16MAY97 in office mom reports 1st seeing dime size area on lt thigh today area is 4cm x 2.5cm red, indurated, warm;MD notes local cellulitis vs varivax rxn;
Dose given too soon. Dose given at 21 days, not 28 days.
Patient developed onset of confusion, headache, and eventually syncope approximately 3 days after the receipt of multiple vaccines.  12/04/09 ED received for DOS 11/25/07 DX: Altered mental status Pt presented to ED with throbbing headache, focal sz of UE, neck pain, asymmetrical pupils,  and unable to give his last name.  On examination: flat affect, confusion, responds inappropriately, neck pain. Pt discharged home.  12/07/09 MR for DOS 09/24/09: DX: Allergic rhinitis, esophagitis eosonophilic.   Pt c/o diarrhea after eating foods. Pt suggested to start elemental diet. Pt to follow up with the allergist.
Pt become nauseated and vomited, post vax, of HBV. Pt was layed down and informed she could leave facility once she was ok, if she did not have any problems. At 11:00, no complaints at this time to me other than a headache; has not eaten yet today. No nausea and vomiting currently and states she is able to walk now. Grandmother is taking her home and should eat. At 15:30, grandmother called and said pt still has a headache and took Tylenol. At 23:30, has eaten and kept food down, Informed to try ice pack and drink small amount of orange juice and try Advil or Motrin in about 2 hours. If problems persist or worsen, go to MD or ER. Informed that I would call and check on her tomorrow, if I did not hear from her again today. On 01/10/01 at 08:50, grandmother says child is ok and returned to school today.
myocarditis/pericarditis. heart pain, chest tightness, sweating, increased blood pressure, exhaustion.  Symptoms continued for 8 weeks. Symptoms resolved for 4 weeks then reappeared.
soreness in his arm; body aches; a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported adverse event).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever). At the time of the report, PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever) outcome was unknown.            No Concomitant information  provided. No Treatment information  provided
severe headache, general flu-like symptoms started 4 hours after vaccine and lasted 36 hours
Moderna 2/5/21, 3/5/21. Pfizer 11/9/21, 6/3/22. Positive on 10/30/22
hip flexor pain; This is a spontaneous report from contactable Physician (Patient). This Physician reported similar events for three patients. This report is for 1st of three patient.  A 50-years-old female patient received bnt162b2 (BNT162B2, BNT162B2 Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 19Jan2021 17:30 (Batch/Lot Number: EL3249) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 09Feb2021 (Batch/Lot Number: EM9810) as DOSE 2, SINGLE for covid-19 immunisation. Not pregnant at the time of vaccination. No other vaccine in four weeks. No covid prior vaccination. Covid not tested post vaccination. Medical history included hypertension, anxiety, attention deficit hyperactivity disorder, methylenetetrahydrofolate reductase deficiency, cytochrome P450 2D6 deficiency, food allergy. Concomitant medication(s) included escitalopram oxalate (LEXAPRO); losartan potassium (COZAAR); dexmethylphenidate hydrochloride (FOCALIN XR ER); melatonin (MELATONIN). The patient previously took and experienced drug hypersensitivity (Thimerasol, sensitive to gluten, eggs, cheese). On 24Jan2021 patient experienced hip flexor pain. Patient received second dose (Pfizer EM9810) last night (09Feb2021) no new adverse reactions at this time. The adverse event result in any Doctor or other healthcare professional office/clinic visit. Treatment received for event includes Physical therapy. Approximately 5 days after vaccine, I started to get hip flexor pain. I do yoga regularly and did nothing that should have caused me this amount of pain that affects my daily activities (driving, putting on clothes, etc.). I'm now seeing a physical therapist for it. The pain/inflammation has now moved to ITB area. Doesn't make sense. I'm an EM physician. I know 2 others with similar experiences, and I've advised them to contact you also. Keep up the good work! Thank you for all that you do! The outcome of event was not recovered.    Follow-up (13May2021): Follow-up attempts completed. No further information expected.